Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AXIM - AXIM Bio nabs additional US patent for anti-neoplastic compounds

AXIM - AXIM Bio nabs additional US patent for anti-neoplastic compounds

Axim Biotechnologies Inc
The USPTO has issued a new Notice of Allowance to AXIM Biotechnologies ([[AXIM]] +0.4%) for a patent on anti-neoplastic compounds and methods targeting Quiescin Sulfhydryl Oxidase 1, an enzyme important for tumor cell growth, invasion and metastasis.Earlier this year, AXIM's subsidiary Sapphire Biotech, received exclusive licensed patents on behalf of ASU and the Mayo Clinic. SBI-183 is also covered by this patent that selectively targets QSOX1 in animal models.AXIM intends to continue generating and testing analogs of SBI-183 to discover the most biologically active form of the compound. Currently, SPX-1009 has  shown to be tenfold more potent in suppressing tumor invasion and metastasis in vitro than SBI-183.

For further details see:

AXIM Bio nabs additional US patent for anti-neoplastic compounds
Stock Information
Company Name: Axim Biotechnologies Inc
Stock Symbol: AXIM
Market: OTC
Website: aximbiotech.com
Menu
AXIM AXIM Quote AXIM Short AXIM News AXIM Articles AXIM Message Board
Get AXIM Alerts

News, Short Squeeze, Breakout and More Instantly...